Koninklijke Philips N.V.

NYSE:PHG

Medical - Devices

Healthcare
$29.81 +2.17%

+$0.57 today

Market cap
$29.11B
Beta
0.93
P/E (TTM)
23.1
EPS (TTM)
$1.02
Dividend yield
3.62%
52W Low $22.20High $33.44

Volume 1.45M

Average 1.17M

PHG Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Koninklijke Philips N.V.NYSE: PHG

Other Income / Expenses · Q2 FY2026 · quarter ended Jun 2026

Other income / expenses remains negative

Q2 FY2026 other income / expenses was -€64M, compared with -€63M a year earlier. Trailing-twelve-month other income / expenses was -€244M.

Context

  • Other income / expenses amounted to 1.4% of revenue in FY2025, down 0.9 pp from a year earlier.
  • Other income / expenses grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -€64M or moves back toward the trailing-twelve-month quarterly average of -€61M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
-€64M-25.5% QoQ
Last fiscal yearDec 2025
-€242M+40.4% YoY
LTMJun 2026
-€244M+14.4% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.6%——
1 year+40.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

EUR · from the income statement

Latest · FY2025
(242M) EUR
Year-over-year change
+40.4%

Other Income / Expenses vs competitors

How PHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +14.4% is the 5th highest of 10, against a peer median of +13.1%.
  • Other income / expenses amounts to 1.4% of revenue for PHG, versus a peer median of 2.6%.
PHG Competitors
Other Income / Expenses for PHG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
RMDResMed Inc.LTM Jun 2026$26.76M USD+443.2%—0.5%
IRMDIRadimed CorporationLTM Mar 2026$2.23M USD-4.2%+58.8%2.6%
NPCENeuroPace, Inc.LTM Mar 2026-$4.81M USD+13.1%—4.8%
SNNSmith & Nephew plcFY2025-$15M USD+90.6%—0.2%
LIVNLivaNova PLCLTM Sep 2026-$53.12M USD+86.2%—3.5%
MDTMedtronic plcLTM Jul 2026-$183M USD+60.2%—0.5%
PHGKoninklijke Philips N.V.LTM Jun 2026-€244M EUR+14.4%—1.4%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026-$528M USD-1527.0%—2.6%
BSXBoston Scientific CorporationLTM Jun 2026-$645M USD-3171.4%—3.1%
ABTAbbott LaboratoriesLTM Sep 2026-$789M USD-324.8%—1.6%
Peer median (excluding PHG) —+13.1%+58.8%2.6%

Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.16B17.83B18.17B18.02B17.83B
Cost of Revenue9.99B10.63B10.72B10.25B9.78B
Gross Profit7.17B7.19B7.45B7.77B8.06B
Gross Margin41.8%40.4%41.0%43.1%45.2%
Research & Development1.81B2.09B1.89B1.75B1.7B
Selling, General & Admin4.86B5.29B5.13B5.07B4.97B
Operating Expenses6.62B8.72B7.56B7.24B6.63B
Depreciation & Amortization1.32B1.6B1.26B1.39B1.13B
EBITDA2B115M1.04B1.85B2.64B
EBITDA Margin11.6%0.6%5.7%10.3%14.8%
Operating Income553M(1.53B)(115M)529M1.42B
Operating Margin3.2%-8.6%-0.6%2.9%8.0%
Interest Income18M25M46M79M108.54M
Interest Expense164M244M306M337M332.34M
Other Income / Expenses(44M)(202M)(412M)(406M)(242M)
Income Before Tax509M(1.73B)(527M)123M1.18B
Pre-Tax Margin3.0%-9.7%-2.9%0.7%6.6%
Income Tax Expense(103M)(113M)(73M)963M282M
Net Income3.32B(1.61B)(466M)(702M)895M
Net Margin19.3%-9.0%-2.6%-3.9%5.0%
EPS (Basic)0.67(1.68)(0.49)(0.75)0.95
EPS (Diluted)0.64(1.68)(0.49)(0.75)0.93
Weighted Avg Shares907.46M952.46M948.79M933.37M962.37M
Weighted Avg Shares (Diluted)950.28M952.46M948.79M933.37M962.5M

Koninklijke Philips N.V.

NYSE:PHG

Intrinsic Alpha fair value

Locked

Current Price

$29.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.